Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-10-18

FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved Westminster Pharmaceuticals' supplemental application for risperidone under an ANDA, confirming approval of a change associated with the generic dr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)